Schering Licensing Decisions To Focus On Boosting Sales Efficiency – Hassan
Executive Summary
Schering-Plough's licensing efforts will focus on bringing in compounds that will increase the efficiency of the firm's marketing efforts, CEO Fred Hassan suggested during an interview with "The Pink Sheet."
You may also be interested in...
Pfizer R&D Emphasizes M&A; Deal Structure, Integration To Be More Flexible
Pfizer anticipates that one-third of the six new products the company expects to launch annually beginning in 2011 will derive from enhanced external sourcing efforts
Pfizer R&D Emphasizes M&A; Deal Structure, Integration To Be More Flexible
Pfizer anticipates that one-third of the six new products the company expects to launch annually beginning in 2011 will derive from enhanced external sourcing efforts
Schering-Plough To Hone Its Edge In “Build The Base” Phase
Schering-Plough is in a strong financial position for deal-making as it moves into the "build the base" phase of its restructuring initiative, where the firm is actively looking for acquisitions to bolster its R&D portfolio, CEO Fred Hassan said during the company's third quarter earnings call Oct. 20